| Oral Vitamin C for Correction of Anemia in Patients Receiving Peritoneal Dialysis (NCT00920413) | Unity Health Toronto | 2002-03-01 |
| A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia (NCT00048035) | Hoffmann-La Roche | 2002-03-01 |
| Efficacy and Safety Study of SAL-0951 in the Treatment of Renal Anemia in Patients Receiving Peritoneal Dialysis (NCT06720233) | Shenzhen Salubris Pharmaceuticals Co., Ltd. | 2002-02-22 |
| Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and Ribavirin (NCT00194857) | Weill Medical College of Cornell University | 2002-02-01 |
| A Study to Evaluate PROCRIT (Epoetin Alfa) for Maintenance Phase Treatment of Patients With Anemia Due to Chronic Kidney Disease (PROMPT) (NCT00307814) | Ortho Biotech Products, L.P. | 2002-01-01 |
| Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer (NCT00301912) | University of California, San Francisco | 2002-01-01 |
| Anemia in Patients With a Non-Myeloid Malignancy (NCT00038064) | Amgen | 2002-01-01 |
| Blood Products in Cardiac Surgery (NCT02068755) | University of Turku | 2002-01-01 |
| Chemotherapy Related Anemia (NCT00035607) | Amgen | 2001-12-01 |
| A Study of Mircera in Anemic Patients With Multiple Myeloma (NCT00360347) | Hoffmann-La Roche | 2001-11-29 |
| A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia. (NCT00364832) | Hoffmann-La Roche | 2001-10-01 |
| A Study to Evaluate the Erythropoietic Response in Hepatitis C Virus (HCV) Patients Receiving Combination Ribavirin (RBV)/Interferon (IFN) Therapy or RBV/PEG IFN (NATURAL HISTORY-HCV) (NCT00328549) | Ortho Biotech Products, L.P. | 2001-10-01 |
| Impacts of the 10 Steps for Healthy Feeding in Infants: a Randomized Field Trial (NCT00629629) | Federal University of Health Science of Porto Alegre | 2001-10-01 |
| Study to Develop a Screening Tool for Functional Capacity in Anemic Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Darbepoetin Alfa (NCT00540696) | Amgen | 2001-09-01 |
| Will Radiation/Chemotherapy Treatment of Cervical Cancer Work Better With Medication That May Improve Anemia? (NCT00039884) | Mirhashemi, Ramin, M.D. | 2001-09-01 |
| Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia (NCT00017004) | Gynecologic Oncology Group | 2001-08-01 |
| Proteases in Patients With Prostate Cancer That Has Spread to the Bone (NCT00899665) | Barbara Ann Karmanos Cancer Institute | 2001-07-01 |
| Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome (NCT00053001) | Fallon Clinic | 2001-06-01 |
| Comparison of Oral Iron With IV Iron in Patients With Anemia of Chronic Renal Failure Not on Dialysis (NCT00236964) | American Regent, Inc. | 2001-02-23 |
| Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20) (NCT00310232) | Ontario Clinical Oncology Group (OCOG) | 2001-02-01 |
| Effects of Early Correction of Anemia in Patients With Chronic Renal Insufficiency (NCT00312871) | Janssen Cilag S.A.S. | 2001-02-01 |
| NATURAL HISTORY-Hepatitis C Virus/ Human Immunodeficiency Virus Coinfection (NCT00315432) | Ortho Biotech Products, L.P. | 2000-09-01 |
| A Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) or Placebo on Anemia and Quality of Life in Children With Cancer Undergoing Chemotherapy (NCT00261677) | Ortho Biotech Products, L.P. | 2000-08-01 |
| A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia (NCT00321919) | Hoffmann-La Roche | 2000-07-01 |
| Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer (NCT00004917) | Radiation Therapy Oncology Group | 2000-06-01 |
| A Study to Evaluate the Impact of Maintaining Hemoglobin Levels Using Epoetin Alfa in Patients With Metastatic Breast Cancer Receiving Chemotherapy (NCT00211133) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2000-06-01 |
| A Study of the Safety and Efficacy of Long-term Correction of Anemia With Epoetin Alfa in Early Hemodialysis Patients (NCT00261521) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2000-02-01 |
| Exercise Plus Epoetin Alfa in Treating Cancer Patients Who Have Anemia-Related Fatigue (NCT00004914) | Northwestern University | 2000-01-01 |
| Exploring the Comorbidity Between Mental Disorders and General Medical Conditions (NCT03847753) | University of Aarhus | 2000-01-01 |
| The Effect of Epoetin Alfa on Cardiac Function and Quality of Life in Patients With Early Renal ((Kidney) Disease (NCT00446576) | Janssen-Cilag B.V. | 1999-11-01 |
| A Study of the Effectiveness and Safety of Treatment With Epoetin Alfa on Hemoglobin Levels, Red Blood Cell Transfusions, and Quality of Life in Patients With Cancer Receiving Platinum-containing Chemotherapy (NCT00283465) | Janssen-Cilag B.V. | 1999-11-01 |
| A Novel Erythropoiesis Stimulating Protein (NESP; Darbopoetin Alfa) for the Treatment of Anemia in Lung Cancer Patients Receiving Multi-cycle Platinum-Containing Chemotherapy (NCT03776032) | Amgen | 1999-09-14 |
| Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia (NCT00004215) | Memorial Sloan Kettering Cancer Center | 1999-08-01 |
| Dose-finding Study of Novel Erythropoiesis Stimulating Protein (NESP) for the Treatment of Anaemia in Subjects With Solid Tumours Receiving Multicycle Chemotherapy (NCT00540384) | Amgen | 1999-07-01 |
| The Effect of PROCRIT (Epoetin Alfa) on Postoperative Vigor and Handgrip Strength (VIGOR Study) (NCT00401869) | Ortho Biotech, Inc. | 1999-02-01 |
| The Jiaxing Birth Cohort in China (NCT03217656) | Zhejiang University | 1999-01-01 |
| Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy (NCT00003600) | Alliance for Clinical Trials in Oncology | 1998-12-01 |
| Bone Marrow Transplantation in Treating Patients With Hematologic Cancer (NCT00003398) | University of Maryland, Baltimore | 1998-09-01 |
| Amifostine With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome (NCT00003681) | European Organisation for Research and Treatment of Cancer - EORTC | 1998-08-01 |
| Erythropoietin Treatment in Extremely Low Birth Weight Infants (NCT00593801) | Charite University, Berlin, Germany | 1998-05-01 |
| A Study to Confirm the Safety and Efficacy of Epoetin Alfa (PROCRIT) Administered Perioperatively vs. the Standard of Care in Blood Conservation in Patients Undergoing Major Elective Spinal Surgery (SPINE Study) (NCT00211146) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1998-04-01 |
| Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes (NCT00003138) | Eastern Cooperative Oncology Group | 1998-03-04 |
| A Safety and Efficacy Study for Epoetin Alfa in Pre-dialysis Subjects. (NCT00364260) | Janssen-Ortho Inc., Canada | 1997-12-01 |
| Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine (NCT00001533) | National Heart, Lung, and Blood Institute (NHLBI) | 1996-09-01 |
| Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy (NCT00270127) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1996-08-01 |
| A Study to Determine an Effective Dose of Epoetin Alfa to Decrease the Number of Units of Blood Required to be Transfused During Hip Replacement Surgery. (NCT00269971) | Janssen-Ortho Inc., Canada | 1996-05-01 |
| RCT Iron Supplementation and Malaria Chemoprophylaxis for Prevention of Severe Anemia and Malaria in Tanzanian Infants (NCT00497471) | Hospital Clinic of Barcelona | 1995-02-01 |
| The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy (NCT00270166) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1995-02-01 |
| The Effect of Epoetin Alfa on the Anemia of Patients With Multiple Myeloma (NCT00270101) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1995-01-01 |
| Erythropoietin Therapy in Patients With Chronic Renal Failure: A Study of Time Dependent Activity (NCT00744445) | Sunnybrook Health Sciences Centre | 1993-10-01 |
| A Study to Determine Whether Epoetin Alfa Can Reduce the Need for Blood Transfusions in Patients During the Period of Time Around Major Orthopedic Surgery. (NCT00270088) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1993-04-01 |
| Liberal Versus Restrictive Transfusion Guidelines for Preterm Infants (NCT00369005) | University of Iowa | 1992-12-01 |
| A Study to Determine the Safety of Epoetin Alfa and Whether Epoetin Alfa Can Reduce the Need for Blood Transfusions in Patients After Major Orthopedic Surgery. (NCT00270036) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1991-04-01 |
| Epoetin Alfa for the Treatment of Anemia Resulting From Chronic Lymphocytic Leukemia (NCT00270049) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1990-11-01 |
| Anemia and Surgery: Indications For Transfusion (NCT00005308) | National Heart, Lung, and Blood Institute (NHLBI) | 1990-04-01 |
| A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Facilitating the Presurgical Collection of Blood to be Used for Self-donation During Surgery on the Spine, Hip, or Knee. (NCT00270140) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1989-09-01 |
| A Study to Evaluate the Safety of Epoetin Alfa and Its Effectiveness in Facilitating the Presurgical Collection of Blood From Anemic Patients for Possible Self-transfusion During and After Scheduled Joint Surgery. (NCT00270062) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1989-05-01 |
| Erythropoietin for Anemia Due to Zidovudine in Human Immunodeficiency Virus Infection (NCT00000587) | Thomas Jefferson University | 1988-09-01 |
| A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in Patients With Acquired Immunodeficiency Syndrome (AIDS) Who Are Receiving Zidovudine (AZT) Therapy (NCT00270283) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1988-07-01 |
| Epoetin Alfa in Treating Chemotherapy-Related Anemia in Women With Stage I, Stage II, or Stage III Breast Cancer (NCT00022386) | Jonsson Comprehensive Cancer Center | |
| A Study of the Safety and Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Patients Who Are Undergoing Orthopedic Surgery and Who Have Low Hematocrit Levels (the Percent of Red Blood Cells in Whole Blood) (NCT00270114) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| A Study to Determine the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Patients With Persistent Anemia Caused by Advanced Cancer (NCT00269984) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| A Study of NeoRecormon in Patients With Chronic Kidney Disease. (NCT00437723) | Hoffmann-La Roche | |
| Expanded Access Protocol Using HBOC-201 (NCT02684474) | Johns Hopkins University | |
| Open-Label Extension Safety Study of PROCRIT in Patients With Anemia of Chronic Disease Due to Rheumatoid Arthritis (NCT00123149) | Ortho Biotech Products, L.P. | |
| A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo to Reduce the Need for Blood Transfusions and Reduce the Occurrence of Severe Anemia During the Time Period Surrounding Total Hip Replacement Surgery (NCT00269958) | Janssen-Ortho Inc., Canada | |
| A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their Disease (NCT00269945) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| Study of the Safety and Effectiveness of Rilonacept (IL-1 Trap) Administered Subcutaneously in Subjects With Non Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) and Anemia (NCT00609544) | Regeneron Pharmaceuticals | |
| Evaluation of an Intervention Program for the Prevention of Anemia (NCT00436202) | Wolfson Medical Center | |
| A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Patients With Persistent Anemia as a Result of Cancer Treatment With Cisplatin, a Platinum-containing Chemotherapy Drug (NCT00269997) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| A Phase 2 Study to Evaluate the Safety and Effectiveness of Once Weekly or Once Every Two Week Dosing of Epoetin Alfa in Anemic Patients With Low- or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) (NCT00446602) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| HBOC-201 Expanded Access Protocol for Life-threatening Anemia for Whom Allogeneic Blood Transfusion is Not an Option (NCT02934282) | Mauricio Lynn | |
| A Study of AMG 114 Administered by Subcutaneous Injection for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy (NCT00119600) | Amgen | |
| Study of Transplant Related Anemia Treated With Aranesp® (STRATA) (NCT00117065) | Amgen | |
| A Study of NeoRecormon (Epoetin Beta) in Patients With Renal Anemia. (NCT00440063) | Hoffmann-La Roche | |
| Study for the Treatment of Anemia in Patients With Non-myeloid Malignancies Receiving Multicycle Chemotherapy. (NCT00148421) | Amgen | |
| A Study of NeoRecormon (Epoetin Beta) in Patients With End Stage Renal Disease. (NCT00413101) | Hoffmann-La Roche | |
| A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) Therapy (NCT00270270) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their Disease (NCT00270010) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| A Study to Evaluate the Effectiveness and Safety of Epoetin Alfa During the Period When One is Donating One's Own Blood Before Surgery. (NCT00270179) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| Evaluating Treatment of Anemia in Subjects With Non-Myeloid MalignanciesReceiving Multicycle Chemotherapy (NCT00111462) | Amgen | |